13.07.2015 Views

Dilemma in Gastrointestinal Decontamination - SUNY Upstate ...

Dilemma in Gastrointestinal Decontamination - SUNY Upstate ...

Dilemma in Gastrointestinal Decontamination - SUNY Upstate ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CentralNew YorkRegionalPoisonControlCenterThe CNYPCCToxicology LetterApril, 2001Vol. VI No. 2SCHEDULED EVENTS:Emergency Medic<strong>in</strong>e Grand RoundsHealth Sciences Library Room 318Second Wednesday of the Month, 11:00 AMApril 11, 2001, 11:00 AMMay 9, 2001, 11 AMJune 13, 2001, 11 AMToxicology Case ConferenceCNYPCC, 550 E Genesee StreetPoison Center Conference RoomEvery Thursday 1:30 PM – 2:30 PMPROGRAM ANNOUNCEMENT:The Fifth Annual Toxicology Teach<strong>in</strong>g Day willbe held on November 7, 2001 at theUniversity Sheraton.A flyer will be com<strong>in</strong>g shortly. If you would likeadvance <strong>in</strong>formation, please call315-464-7078.CNYPCC TIDBITS:Toxic Alcohols – Match to the AlcoholA. methanol 1. renal failureB. isopropanol 2. ketosis withoutacidosisC. ethylene glycol 3. ocular toxicityD. propylene glycol 4. lactic acidformationTOX TRIVIA:1. What is the tox<strong>in</strong> responsible forWoolsorter’s disease?2. What was the tox<strong>in</strong> released <strong>in</strong> Bopol?3. What homicidal poison is associated withburn<strong>in</strong>g toes, hair loss and multi-systemorgan failure?CaseHistoryA Quarterly PublicationContributed by: T. Michele Caliva, RN, CSPI, Christ<strong>in</strong>e M. Stork,Pharm.D., ABATDILEMMA IN GASTROINTESTINAL DECONTAMINATIONPatients who are exposed to a tox<strong>in</strong> require a thorough <strong>in</strong>itialassessment before appropriate management decisions can be made.The assessment should <strong>in</strong>clude:●Evaluation of airway, breath<strong>in</strong>g and circulation●Assessment of mental status and r/o hypoglycemia●ECG, <strong>in</strong>clud<strong>in</strong>g QRS measurements, especially <strong>in</strong> acuteoverdoses to r/o exposure to tricyclic antidepressants or othersodium channel antagonists●Patient and exposure history●Physical exam and rout<strong>in</strong>e basel<strong>in</strong>e labs●Toxidrome identification.Once the patient assessment is completed and immediate lifesav<strong>in</strong>g<strong>in</strong>terventions have been performed, it is time to consider therole of gastro<strong>in</strong>test<strong>in</strong>al decontam<strong>in</strong>ation. The goal of gastro<strong>in</strong>test<strong>in</strong>aldecontam<strong>in</strong>ation is to remove a harmful substance from the bodybefore it can be absorbed and cause systemic toxicity. Currentlyavailable methods of gastro<strong>in</strong>test<strong>in</strong>al decontam<strong>in</strong>ation <strong>in</strong>clude syrup ofipecac, orogastric lavage, activated charcoal, and whole bowelirrigation. We will address the appropriate use of the variousgastro<strong>in</strong>test<strong>in</strong>al decontam<strong>in</strong>ation methods available us<strong>in</strong>g casedemonstrations.Case A: A 40-year-old unresponsive male is brought to theEmergency Department via ambulance. An empty bottle of # 100Aspir<strong>in</strong> 325 mg tablets, as well as empty bottles of various coldmedications were found <strong>in</strong> the patient’s home.Case B: A 16-year-old male presents to the EmergencyDepartment after <strong>in</strong>gest<strong>in</strong>g an unknown amount of Benadryl and 2beers.Orogastric LavageOrogastric lavage is most effective early after exposure, preferablywith<strong>in</strong> 1 hour, but is also useful later <strong>in</strong> cases where residual drug maybe <strong>in</strong> the stomach. Orogastric lavage should be accomplished us<strong>in</strong>gthe largest tube possible (40 F <strong>in</strong> adults and 24-28 French <strong>in</strong> children).With the patient <strong>in</strong> the left lateral decubitus position and airwayadequately protected, normal sal<strong>in</strong>e (200-300 mL <strong>in</strong> adults and 10mL/kg <strong>in</strong> a child) is <strong>in</strong>stilled and withdrawn at regular <strong>in</strong>tervals until thefluid is clear. Orogastric lavage should not be considered <strong>in</strong> patientswho have <strong>in</strong>gested a tox<strong>in</strong> that is easily aspirated, such as a hydrocar-CNY POISON CONTROL CENTER ● 750 EAST ADAMS STREET ● SYRACUSE, NY 13210 ● 315-476-4766


DILEMMA IN GASTROINTESTINAL DECONTAMINATIONbon, is corrosive to the gastro<strong>in</strong>test<strong>in</strong>al tract (there aresome exceptions), or when there is a medical or surgicalcondition compromis<strong>in</strong>g the <strong>in</strong>tegrity of the gastro<strong>in</strong>test<strong>in</strong>altract. Complications of orogastric lavage <strong>in</strong>cludeaspiration pneumonia, <strong>in</strong>jury to the throat, stomach, oresophagus, or fluid and electrolyte imbalance. Studies <strong>in</strong>healthy subjects f<strong>in</strong>d that the amount of a given substanceremoved via orogastric lavage varies from 32% to8% depend<strong>in</strong>g on the substance. Factors that <strong>in</strong>fluencethe efficacy of lavage <strong>in</strong>clude: tox<strong>in</strong> location <strong>in</strong> thegastro<strong>in</strong>test<strong>in</strong>al tract, size of pills or substances <strong>in</strong>gested,and the size of lavage tube. Large trials <strong>in</strong> poisonedpatients failed to demonstrate a change <strong>in</strong> outcome forthe majority of patients treated with orogastric lavage vs.activated charcoal alone. As a result, orogastric lavage isnow reserved for patients who, by history or physicalexam<strong>in</strong>ation, are thought to have <strong>in</strong>gested a life-threaten<strong>in</strong>gamount of a tox<strong>in</strong>. Case A meets this criteria becauseof the dose <strong>in</strong>gested, while case B does not.Case A: A 2-year-old female is play<strong>in</strong>g <strong>in</strong> the backyardwith her father . She picks up a mushroom and eats it.Dad witnesses the <strong>in</strong>gestion and attempts to remove themushroom from her mouth. He is able to remove somebut the child swallows most of it.Case B: An 18 month old boy reaches up on thecounter and dr<strong>in</strong>ks 3 ounces of acetam<strong>in</strong>ophen liquidfrom an open conta<strong>in</strong>er. The amount <strong>in</strong>gested wascalculated to be 180mg/kg.Syrup of IpecacSyrup of Ipecac is derived from the roots of C.acum<strong>in</strong>ata or C. ipecacuanha. The active components ofthese plants are the alkaloids, cephal<strong>in</strong>e and emet<strong>in</strong>e.Syrup of ipecac produces vomit<strong>in</strong>g through both directirritation, and through stimulation of the chemoreceptortrigger zone (vomit<strong>in</strong>g center) <strong>in</strong> the bra<strong>in</strong>. The dose is 30mL <strong>in</strong> adults, 15 mL for children 1-12 years of age and 10mL for children 6 months to 1 year of age. Emesis isexpected <strong>in</strong> 20-30 m<strong>in</strong>utes and the dose can be repeatedonce. Similar to orogastric lavage, syrup of ipecacremoves approximately 30% of a tox<strong>in</strong> if adm<strong>in</strong>isteredwith<strong>in</strong> the first hour after <strong>in</strong>gestion. Also, similar toorogastric lavage, studies do not demonstrate a change<strong>in</strong> outcome due to adm<strong>in</strong>istration of syrup of ipecac <strong>in</strong> themajority of cases. The <strong>in</strong>ability to use syrup of ipecac <strong>in</strong>patients with a potential for a change <strong>in</strong> mental status,seizures, or where an oral antidote will be effective hasled to its dim<strong>in</strong>ished use. Syrup of ipecac may be ofsome value <strong>in</strong> the scenario described <strong>in</strong> Case A, wherethe <strong>in</strong>gestion is early and witnessed, and there is apotential for delayed toxicity which may be life threaten<strong>in</strong>g.In Case B, the use of syrup of ipecac would not be<strong>in</strong>dicated because this patient has taken a toxic amountof acetam<strong>in</strong>ophen (above 150mg/kg) which requires(CONT.)activated charcoal and may also require oral antidoteadm<strong>in</strong>istration.Case A: A 29-year-old female presents to the ED after<strong>in</strong>gest<strong>in</strong>g several 500mg acetam<strong>in</strong>ophen tablets. Shestates that the <strong>in</strong>gestion occurred 1 hour ago.Case B: A five-year-old male and his 3-year-old sisterpresent to the ED after <strong>in</strong>gest<strong>in</strong>g several pre-natalvitam<strong>in</strong>s with iron.S<strong>in</strong>gle Dose Activated charcoal (SDAC):Activated charcoal is a black odorless powder that isproduced from wood or coconut that is burned and thentreated with steam or carbon dioxide. It is available both<strong>in</strong> the powder or aqueous form. It is the latter form that ismost often used <strong>in</strong> the healthcare sett<strong>in</strong>g. The dose of ACis 1 g/kg orally which is the largest, well- tolerated dose <strong>in</strong>most patients. Activated charcoal adheres to tox<strong>in</strong>s <strong>in</strong> thegastro<strong>in</strong>test<strong>in</strong>al tract, thereby prevent<strong>in</strong>g absorption <strong>in</strong>tothe body and thus prevent<strong>in</strong>g systemic toxicity. It is mosteffective when adm<strong>in</strong>istered early where it is more likelyto reach the tox<strong>in</strong> <strong>in</strong> the gastro<strong>in</strong>test<strong>in</strong>al tract, but cont<strong>in</strong>uesto be of use later <strong>in</strong> select circumstances. Sometox<strong>in</strong>s, such as alcohols, heavy metals, lithium, and ironadhere poorly to activated charcoal, if at all. Activatedcharcoal should not be adm<strong>in</strong>istered if there is medical,surgical, or chemical (i.e. caustic <strong>in</strong>gestion) gastro<strong>in</strong>test<strong>in</strong>alcompromise. In Case A, adm<strong>in</strong>istration of activatedcharcoal is <strong>in</strong>dicated as it is shown to effectively loweranticipated acetam<strong>in</strong>ophen serum concentrations. InCase B, activated charcoal would be of limited valueunless a co-<strong>in</strong>gestant is considered, because it does notb<strong>in</strong>d to iron.Multiple-Dose Activated Charcoal (MDAC):Case A: A 50-year-old female presents to the ED after<strong>in</strong>gest<strong>in</strong>g 20 Valium tablets.Case B: A 19-year-old male is brought <strong>in</strong> by ambulanceafter admitt<strong>in</strong>g that he <strong>in</strong>gested several susta<strong>in</strong>edrelease Theophyll<strong>in</strong>e tablets. Multiple dos<strong>in</strong>g of activatedcharcoal may be beneficial <strong>in</strong> those cases where a largeamount of a tox<strong>in</strong> is <strong>in</strong>gested and it is unlikely that as<strong>in</strong>gle dose of activated charcoal (1g/kg) would beenough to result <strong>in</strong> the desired b<strong>in</strong>d<strong>in</strong>g ratio of 10:1(activated charcoal to drug). In addition, multiple doses ofactivated charcoal should be considered for those tox<strong>in</strong>sthat exhibit enterohepatic metabolism of an activemetabolite or those that can exhibit enteroenteric recirculation.The frequency of multiple doses of activatedcharcoal is determ<strong>in</strong>ed by the relative efficacy of theactivated charcoal <strong>in</strong> relation to the severity of theanticipated effects of the tox<strong>in</strong>. Generally, 0.25-2g/kg ofactivated charcoal can be used every 1-6 hours. Commontox<strong>in</strong>s that exhibit enterohepatic recirculation of anCNY POISON CONTROL CENTER ● 750 EAST ADAMS STREET ● SYRACUSE, NY 13210 ● 315-476-4766


DILEMMA IN GASTROINTESTINAL DECONTAMINATIONactive metabolite <strong>in</strong>clude amitriptyl<strong>in</strong>e, carbamazep<strong>in</strong>e,and dapsone. Enteroenteric re-circulation occurs whenthere is a negative relative concentration of tox<strong>in</strong> <strong>in</strong> thegut, and tox<strong>in</strong> diffuses passively from the mesentericcirculation <strong>in</strong>to the gut lumen and is trapped. Examples oftox<strong>in</strong>s that exhibit enteroenteric recirculation <strong>in</strong>cludetheophyll<strong>in</strong>e, phenobarbital, and phenyto<strong>in</strong>. Case Bwould be an example where multiple dos<strong>in</strong>g of activatedcharcoal is recommend, due to enteroenteric recirculation.Case A does not meet the criteria for multiple dos<strong>in</strong>gof activated charcoal.Whole Bowel Irrigation (WBI)Case A: A 14 year old female presents to the ED after<strong>in</strong>gest<strong>in</strong>g 15 Calan SR tablets.Case B: A 14 year old female presents to the ED afteroverdos<strong>in</strong>g on an unknown amount of Paxil 20 mgtablets.Whole bowel irrigation places large amounts of highmolecular weight polyethylene glycol electrolyte solution(PEG solution) that is electrolyte neutral <strong>in</strong>to the gutlumen <strong>in</strong> an attempt to clear the contents of the gastro<strong>in</strong>test<strong>in</strong>altract <strong>in</strong> a short amount of time. The appropriatedose of PEG solution <strong>in</strong> an adult is 2 L/hr and up to500 ml/hr for children. Cont<strong>in</strong>uous adm<strong>in</strong>istration of thesolution should occur until the rectal effluent is clear (4-6hours). Side effects associated with WBI are limited tonausea, vomit<strong>in</strong>g, and cramp<strong>in</strong>g. Contra<strong>in</strong>dications<strong>in</strong>clude an unstable patient, obstruction and hemorrhage.(CONT.)Because WBI does not have much cl<strong>in</strong>ical data tosupport its use, it is reserved for the clearance of thosetox<strong>in</strong>s where activated charcoal is not useful eitherbecause of adherence properties or because of a largedose of <strong>in</strong>gested tox<strong>in</strong>. In addition, the tox<strong>in</strong> must haveslow absorption qualities for it to be effectively removed.WBI is <strong>in</strong>dicated <strong>in</strong> situations such as Case A, where notonly has a susta<strong>in</strong>ed release product been <strong>in</strong>gested, butthis drug overdose has potentially life-threaten<strong>in</strong>g effectsthat historically occur despite the use of multiple doses ofactivated charcoal. In this case, early and aggressive<strong>in</strong>tervention with WBI is <strong>in</strong>dicated. In Case B, a s<strong>in</strong>gledose of activated charcoal and supportive care are theonly treatment required.Cathartics:The effectiveness of cathartics is not well established.No studies demonstrate that cathartics are beneficialafter tox<strong>in</strong> exposure. It is our position that the use ofcathartics should be considered rarely and on an <strong>in</strong>dividualbasis.References:Pond SM, Lewis-Driver DJ, Williams GM, et al: GastricEmpty<strong>in</strong>g <strong>in</strong> acute overdose: a prospective randomizedcontrolled trial. Med J Australia 1995;163:345-349.Kulig K, Bar-Or D, Cantrill SV et al.: Management ofacutely poisoned patients without gastric empty<strong>in</strong>g. AnnEmerg Med 1985;14:562-567.CNYPCC Tidbits answers:A. 3B. 2C. 1D. 4Tox Trivia answers:1. Anthrax2. Isocyanate3. Thallium (or arsenic)CNY POISON CONTROL CENTER ● 750 EAST ADAMS STREET ● SYRACUSE, NY 13210 ● 315-476-4766


SPI CORNER TOPIC: “NATURAL” VIAGRA - NATURE’S ANSWER TO IMPOTENCEContributed by: Susan Bruce, PharmD CandidateAnyone can buy “viagra” without a prescription. Althoughthese products do not conta<strong>in</strong> Pfizer’s sildenafil - the FDAapproved prescription medication, the Viagra crazecont<strong>in</strong>ues and people will try almost anyth<strong>in</strong>g. This holdstrue especially if it is less expensive than pay<strong>in</strong>g for anoffice visit to a physician and a prescription for Viagra.Follow<strong>in</strong>g are a few examples of the strategies peopleare us<strong>in</strong>g to sell their products, claim<strong>in</strong>g to achieve thesame effects as the real Viagra.Lebanon’s natural version is a wild root, shirsh zallouh, asmall shrub with t<strong>in</strong>y white or yellow flowers and th<strong>in</strong> leaves.It grows wild <strong>in</strong> the mounta<strong>in</strong>s of Lebanon.Apparently, shirsh zallouh has been used <strong>in</strong> Lebanon forgenerations, but its popularity is becom<strong>in</strong>g worldwide. Anextract is made from the root, and a pharmacist <strong>in</strong> Beirutclaims the “taste is a little rough” so it is best to place thedrops <strong>in</strong> milk or juice. Try<strong>in</strong>g to f<strong>in</strong>d <strong>in</strong>formation about theshrub that this product is from is difficult, let alone itsmedic<strong>in</strong>al possibilities. A product called Milagro claims tohave all the nutrients essential for “<strong>in</strong>creased desire,enhanced erectile functions, ejaculatory control and improvedfertility,” even though the actual nutrients are neverlisted. Lu Rong (also known as Deer Antler Velvet) is aCh<strong>in</strong>ese medic<strong>in</strong>e that has been available for 3000 years.The English translation reveals that the product comes from“the soft velvet-like cover<strong>in</strong>g of deer antlers while they arestill grow<strong>in</strong>g and still <strong>in</strong> a cartilag<strong>in</strong>ous state, before theyharden <strong>in</strong>to bone.” Known “<strong>in</strong>gredients” <strong>in</strong>clude calcium,phosphorus, sulfur, magnesium, potassium, sodium,manganese, z<strong>in</strong>c, copper, iron, selenium, cobalt, the majoram<strong>in</strong>o acids, collagen, anti-<strong>in</strong>flammatory prostagland<strong>in</strong>s,gangliosides, natural sex hormones and steroids.Mov<strong>in</strong>g to another part of the globe, Male Plus, the“Amazon Herbal for Men”, conta<strong>in</strong>s four herbs from theAmazon Ra<strong>in</strong>forest. The ma<strong>in</strong> <strong>in</strong>gredient is extract of Muirapuama, which is thought to <strong>in</strong>crease libido and successfullytreat “organic- and psychogenic-related impotency.” Theother <strong>in</strong>gredients (Catuaba [an aphrodisiac], Sarsasparilla,and Damiana [an aphrodisiac]) work with Muira pauma.Herbal Male Formula is a comb<strong>in</strong>ation of the follow<strong>in</strong>g:wildcrafted American g<strong>in</strong>seng, yohimbe bark, Ch<strong>in</strong>ese andKorean g<strong>in</strong>seng, saw palmetto berries, sarsaparilla root,kola nut, g<strong>in</strong>ger rhizome, Siberian g<strong>in</strong>seng, juniper berries,and uva ursi leaves. The makers claim use of the productwill help men who have lost their “maleness” to “providemore male energy, <strong>in</strong>crease sexual drive and desire, andenhance the male sense of well be<strong>in</strong>g.”One last example is androstenedione. Along withstimulation of the user’s sex drive, are the usual claims for<strong>in</strong>creases <strong>in</strong> “muscle size, strength and recovery fromexercise.”The reliability of herbal products and their manufacturersfor the <strong>in</strong>tended therapeutic claim does not need to bereiterated. However, it is important for us to be aware ofwhat is out there and what people are experiment<strong>in</strong>g with.Until regulation of natural products is a function of the FDA,we need to evaluate the little <strong>in</strong>formation available for safetyand efficacy. Poor production lead<strong>in</strong>g to contam<strong>in</strong>atedproducts, or misuse of the products could result <strong>in</strong> harm tothe user, which may lead to a call to the poison center.12 346 78910115DANGEROUS SOUND-ALIKESMedications with similar names are often a source of errorContributed by: Margo M. Spa<strong>in</strong>Down1. CCB, Antiang<strong>in</strong>al, antihypertensive and antimigra<strong>in</strong>e2. I’m a benzodiazep<strong>in</strong>e/anticonvulsant. Sometimes I am given forrestless legs.3. My generic name is piroxicam. Don’t forget food with this pa<strong>in</strong>reliever5. Opiate family found <strong>in</strong> many antihistam<strong>in</strong>es, decongestants andexpectorants7. This antidepressant, SSRI can be fatal if taken with MAOI’s6. CCB, antihypertensive and antiang<strong>in</strong>al agent. I relax coronaryartery smooth muscleAcross4. NSAID – osteoarthritis. May <strong>in</strong>crease phenyto<strong>in</strong> and lithiumlevels.6. Antihypertensive prototype, alpha adrenergic agonist8. Gastric acid pump <strong>in</strong>hibitor9. Antiviral action aga<strong>in</strong>st HIV10. Produces less drows<strong>in</strong>ess that other antihistam<strong>in</strong>es because itdoes not cross the blood-bra<strong>in</strong> barrier11. Anti-<strong>in</strong>fective antiviral protease <strong>in</strong>hibitorAcross: 4. lod<strong>in</strong>e; 6. clonod<strong>in</strong>e; 8. prilosec; 10. seldane; 11. ritonavirDown: 1. cadizensr; 2. klonip<strong>in</strong>; 3. feldene; 5. code<strong>in</strong>e; 6. cardenesr; 7. prozacCNY POISON CONTROL CENTER ● 750 EAST ADAMS STREET ● SYRACUSE, NY 13210 ● 315-476-4766

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!